These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6138045)

  • 21. [Beta-1 and beta-2 blocking activities of a new series of (arylalkoxy) propanolamines].
    Rosell G; Mauleón D; Pujol MD; Granados R
    Arch Farmacol Toxicol; 1986 Apr; 12(1):65-70. PubMed ID: 2874776
    [No Abstract]   [Full Text] [Related]  

  • 22. Relaxant and beta 2-adrenoceptor blocking activities of labetalol, dilevalol, amosulalol and KF-4317 on the rat isolated aorta.
    Doggrell SA
    J Pharm Pharmacol; 1988 Nov; 40(11):812-5. PubMed ID: 2907566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) (author's transl)].
    Heinz N; Hofferber E
    Arzneimittelforschung; 1980; 30(12):2135-9. PubMed ID: 6111325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New beta-sympatholytic agents. Synthesis and pharmacological activity of isomeric benzthiazole and benzoxazole derivates (author's transl)].
    Franke A; Frickel FF; Gries J; Lehmann HD; Lenke D; Ohnsorge U
    Arzneimittelforschung; 1980; 30(11):1831-8. PubMed ID: 6109536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potent new beta2-adrenoceptor blocking agent.
    Imbs JL; Miesch F; Schwartz J; Velly J; Leclerc G; Mann A; Wermuth CG
    Br J Pharmacol; 1977 Jul; 60(3):357-62. PubMed ID: 19116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A search for new beta-adrenoblockaders in the series of 5-phenoxymethyl-1,2,4-oxadiazole derivatives].
    Mashkovskiĭ MD; Iuzhakov SD
    Eksp Klin Farmakol; 1994; 57(3):27-30. PubMed ID: 7914114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenergic blocking effects and cardiodepressant activity of penbutolol and its two optical isomers in the guinea-pig left atrium.
    Badía A; Bermejo P; Jané F
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):445-8. PubMed ID: 6092799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological properties of (+/-)-4-[2-hydroxy-3-(3-(2-methoxyphenoxy)-2-propylamino)propoxy]-1(2H) -isoquinolinone (N-1518), a new combined alpha- and beta-adrenoceptor blocking drug].
    Sugai T
    Nihon Yakurigaku Zasshi; 1990 Sep; 96(3):117-27. PubMed ID: 1980255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
    Fekete MI; Elekes I; Kürti M; Borvendég J
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
    Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
    Clifton JE; Collins I; Hallett P; Hartley D; Lunts LH; Wicks PD
    J Med Chem; 1982 Jun; 25(6):670-9. PubMed ID: 6124636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha 1-adrenoceptor blocking activities of bevantolol hydrochloride(NC-1400) and labetalol in rat isolated thoracic aorta--do they distinguish between subtypes?
    Shiraishi K; Moriya M; Miyake N; Takayanagi I
    Gen Pharmacol; 1992 Sep; 23(5):843-5. PubMed ID: 1358746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic action of a new beta-adrenergic blocking agent, 6-(2-hydroxy-3-isopropylaminopropyloxy)-benzothiazole succinate (KF-577), compared with that of propranolol.
    Tatsuno H; Goto K; Shigenobu K; Kasuya Y
    Eur J Pharmacol; 1976 Nov; 40(1):145-52. PubMed ID: 11105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E
    Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultrashort duration of action.
    Gorczynski RJ; Shaffer JE; Lee RJ
    J Cardiovasc Pharmacol; 1983; 5(4):668-77. PubMed ID: 6193366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beta-adrenoblocking activity and other pharmacological properties of 2-(3-amino-2-hydroxypropoxy)phenyoxymethyl isoxazole derivatives].
    Iuzhakov SD; Zaĭtseva KA; Dorodnikova EV; Mashkovskiĭ MD
    Farmakol Toksikol; 1985; 48(3):36-40. PubMed ID: 2863169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.